AtriCure Inc. | Ownership
Companies that own AtriCure Inc.
Fidelity Management & Research Co.
5,071,107
14.34%
-28,039
0.02%
06/30/2018
Wellington Management Co. LLP
3,261,061
9.22%
-1,300,996
0.02%
06/30/2018
BlackRock Fund Advisors
2,485,926
7.03%
198,730
0%
06/30/2018
T. Rowe Price Associates, Inc.
2,389,867
6.76%
898,494
0.01%
06/30/2018
Hudson Executive Capital LP
2,374,119
6.71%
0
14.69%
06/30/2018
The Vanguard Group, Inc.
1,458,102
4.12%
10,484
0%
06/30/2018
First Light Asset Management LLC
1,380,405
3.9%
212,733
6.34%
06/30/2018
Loomis, Sayles & Co. LP
921,543
2.61%
116,713
0.06%
06/30/2018
Peregrine Capital Management LLC
895,575
2.52%
-170,833
0.72%
06/30/2018
Neuberger Berman Investment Advisers LLC
760,526
2.15%
-19,339
0.03%
06/30/2018
| Address |
7555 Innovation Way
Mason Ohio 45069
United States
|
|
Employees
|
- |
| Website |
http://www.atricure.com |
| Updated |
07/08/2019 |
| AtriCure, Inc. engages provision of treatment of atrial fibrillation and left atrial appendage. It operates through the following geographical segments: United States, Europe, Asia, and Other International. Its product, Isolator Synergy Ablation System, is a surgical device that treats the persistent longstanding persistent forms of atrial fibrillation in patients undergoing certain open concomitant procedures. |
